NIOSH Scientific Information Quality Peer Review Agenda
Information Quality Peer Review Staff
Centers for Disease Control and Prevention
Office of Science Quality
1600 Clifton Road, NE MS D-72
Atlanta, GA 30333
peer.review@cdc.gov
Peer review ensures that the quality of published information meets the standards of the scientific and technical community. Specialists in the field who were not involved in writing the draft document review and provide feedback. Peer reviewers may provide overall comments or respond to specific technical questions posed by the authors.
NIOSH provides information on this page about peer review of Influential Scientific Information (ISI) and Highly Influential Scientific Assessments (HISAs). These documents have a potential impact on public policy or the private sector. Sharing this information demonstrates NIOSH’s efforts to use only the most
- transparent and independent peer review,
- appropriate research methods, and
- highest level of data quality.
In addition, this information demonstrates NIOSH compliance with the Information Quality Act (2000), 44 U.S.C. §3516. NIOSH also complies with the peer review standards developed by the Office of Management and Budget (OMB), Department of Health and Human Services (DHHS), and Centers for Disease Control and Prevention (CDC). The OMB Peer Review Bulletin describes specific requirements. OMB also encourages federal agencies to make specific information on the peer review of influential documents publicly available.
The following NIOSH HISAs and ISI are under development or published in final form:
Highly Influential Scientific Assessments (HISAs) Under Development *
Influential Scientific Information Under Development *
- Draft NIOSH Criteria for a Recommended Standard: Occupational Exposure to Toluene diisocyanate
- Draft NIOSH Technical Report: Approaches to Developing Occupational Exposure Limits or Bands for Engineered Nanomaterials
- Draft NIOSH Criteria for a Recommended Standard: 1-Bromopropane
- NIOSH List of Hazardous Drugs in Healthcare Settings, 2020
- Policy and Procedures for Developing the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings
- A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs
Recently Published HISAs / ISI
- Managing Hazardous Drug Exposures: Information for Healthcare Settings
- Skin Notation Profile for beta-Chloroprene [CAS No. 126-99-8]
- Skin Notation Profile for Chlorodiphenyl (54% chlorine) [CAS No. 11097-69-1]
- Skin Notation Profile for Diacetyl and 2,3-Pentanedione [CAS No: 431-03-8; 600-14-6]
- Skin Notation Profile for Dioxane [CAS No. 123-91-1]
- Skin Notation Profile: 2,4-Toluene diisocyanate (2,4-TDI), 2,6-Toluene diisocyanate (2,6-TDI), 2,4- and 2,6-Toluene diisocyanate mixture [CAS No. 584-84-9; 91-08-7; 26471-62-5]
- Current Intelligence Bulletin 70: Health Effects of Occupational Exposure to Silver Nanomaterials
- Immediately Dangerous to Life or Health Value Profile for Bromine trifluoride
- Immediately Dangerous to Life or Health Value Profile for Chlorine trifluoride
- Immediately Dangerous to Life or Health Value Profile for Ethylene dibromide
- Skin Notation Profile for Chlorodiphenyl (42% chlorine) [CAS: 53469–21–9]
- Skin Notation Profile for Cyclohexanol [CAS: 108–93–0]
- Skin Notation Profile for Cyclohexanone [CAS: 108–94–1]
- Skin Notation Profile for Cyclonite [CAS: 121–82–4]
- Skin Notation Profile for Diethylenetriamine [CAS: 111–40–0]
- Current Intelligence Bulletin 69: NIOSH Practices in Occupational Risk Assessment
- NIOSH Occupational Exposure Banding Process: Guidance for the Evaluation of Chemical Hazards
- Skin Notation Profile for Catechol [CAS# 120-80-9]
- Skin Notation Profile for Sodium fluoroacetate [CAS# 62-74-8]
- Skin Notation Profile for Chlorinated camphene [CAS# 8001-35-2]
- Skin Notation Profile for Atrazine [CAS# 1912-24-9]
- Skin Notation Profile for Pentachlorophenol [CAS# 87-86-5]
* Disclaimer: This information is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by the National Institute for Occupational Safety and Health. It does not represent and should not be construed to represent any agency determination or policy.